Copyright Reports & Markets. All rights reserved.

Global Single-target MET TKIs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Single-target MET TKIs Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Capmatinib
    • 1.3.3 Tepotinib
    • 1.3.4 Savolitinib
    • 1.3.5 Glumetinib
    • 1.3.6 Vebreltinib
    • 1.3.7 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Single-target MET TKIs Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital and Clinic
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Other
  • 1.5 Global Single-target MET TKIs Market Size & Forecast
    • 1.5.1 Global Single-target MET TKIs Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Single-target MET TKIs Sales Quantity (2021-2032)
    • 1.5.3 Global Single-target MET TKIs Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Novartis
    • 2.1.1 Novartis Details
    • 2.1.2 Novartis Major Business
    • 2.1.3 Novartis Single-target MET TKIs Product and Services
    • 2.1.4 Novartis Single-target MET TKIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Novartis Recent Developments/Updates
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Single-target MET TKIs Product and Services
    • 2.2.4 Merck Single-target MET TKIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Merck Recent Developments/Updates
  • 2.3 WuXi STA
    • 2.3.1 WuXi STA Details
    • 2.3.2 WuXi STA Major Business
    • 2.3.3 WuXi STA Single-target MET TKIs Product and Services
    • 2.3.4 WuXi STA Single-target MET TKIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 WuXi STA Recent Developments/Updates
  • 2.4 Shanghai Hutchison Pharmaceuticals
    • 2.4.1 Shanghai Hutchison Pharmaceuticals Details
    • 2.4.2 Shanghai Hutchison Pharmaceuticals Major Business
    • 2.4.3 Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Product and Services
    • 2.4.4 Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Shanghai Hutchison Pharmaceuticals Recent Developments/Updates
  • 2.5 Haihe Biopharma
    • 2.5.1 Haihe Biopharma Details
    • 2.5.2 Haihe Biopharma Major Business
    • 2.5.3 Haihe Biopharma Single-target MET TKIs Product and Services
    • 2.5.4 Haihe Biopharma Single-target MET TKIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Haihe Biopharma Recent Developments/Updates
  • 2.6 CSPC Pharmaceutical
    • 2.6.1 CSPC Pharmaceutical Details
    • 2.6.2 CSPC Pharmaceutical Major Business
    • 2.6.3 CSPC Pharmaceutical Single-target MET TKIs Product and Services
    • 2.6.4 CSPC Pharmaceutical Single-target MET TKIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 CSPC Pharmaceutical Recent Developments/Updates
  • 2.7 Avistone Pharmaceuticals Biotechnology
    • 2.7.1 Avistone Pharmaceuticals Biotechnology Details
    • 2.7.2 Avistone Pharmaceuticals Biotechnology Major Business
    • 2.7.3 Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Product and Services
    • 2.7.4 Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Avistone Pharmaceuticals Biotechnology Recent Developments/Updates
  • 2.8 Asymchem
    • 2.8.1 Asymchem Details
    • 2.8.2 Asymchem Major Business
    • 2.8.3 Asymchem Single-target MET TKIs Product and Services
    • 2.8.4 Asymchem Single-target MET TKIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Asymchem Recent Developments/Updates

3 Competitive Environment: Single-target MET TKIs by Manufacturer

  • 3.1 Global Single-target MET TKIs Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Single-target MET TKIs Revenue by Manufacturer (2021-2026)
  • 3.3 Global Single-target MET TKIs Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Single-target MET TKIs by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Single-target MET TKIs Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Single-target MET TKIs Manufacturer Market Share in 2025
  • 3.5 Single-target MET TKIs Market: Overall Company Footprint Analysis
    • 3.5.1 Single-target MET TKIs Market: Region Footprint
    • 3.5.2 Single-target MET TKIs Market: Company Product Type Footprint
    • 3.5.3 Single-target MET TKIs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Single-target MET TKIs Market Size by Region
    • 4.1.1 Global Single-target MET TKIs Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Single-target MET TKIs Consumption Value by Region (2021-2032)
    • 4.1.3 Global Single-target MET TKIs Average Price by Region (2021-2032)
  • 4.2 North America Single-target MET TKIs Consumption Value (2021-2032)
  • 4.3 Europe Single-target MET TKIs Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Single-target MET TKIs Consumption Value (2021-2032)
  • 4.5 South America Single-target MET TKIs Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Single-target MET TKIs Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Single-target MET TKIs Sales Quantity by Type (2021-2032)
  • 5.2 Global Single-target MET TKIs Consumption Value by Type (2021-2032)
  • 5.3 Global Single-target MET TKIs Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Single-target MET TKIs Sales Quantity by Application (2021-2032)
  • 6.2 Global Single-target MET TKIs Consumption Value by Application (2021-2032)
  • 6.3 Global Single-target MET TKIs Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Single-target MET TKIs Sales Quantity by Type (2021-2032)
  • 7.2 North America Single-target MET TKIs Sales Quantity by Application (2021-2032)
  • 7.3 North America Single-target MET TKIs Market Size by Country
    • 7.3.1 North America Single-target MET TKIs Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Single-target MET TKIs Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Single-target MET TKIs Sales Quantity by Type (2021-2032)
  • 8.2 Europe Single-target MET TKIs Sales Quantity by Application (2021-2032)
  • 8.3 Europe Single-target MET TKIs Market Size by Country
    • 8.3.1 Europe Single-target MET TKIs Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Single-target MET TKIs Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Single-target MET TKIs Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Single-target MET TKIs Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Single-target MET TKIs Market Size by Region
    • 9.3.1 Asia-Pacific Single-target MET TKIs Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Single-target MET TKIs Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Single-target MET TKIs Sales Quantity by Type (2021-2032)
  • 10.2 South America Single-target MET TKIs Sales Quantity by Application (2021-2032)
  • 10.3 South America Single-target MET TKIs Market Size by Country
    • 10.3.1 South America Single-target MET TKIs Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Single-target MET TKIs Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Single-target MET TKIs Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Single-target MET TKIs Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Single-target MET TKIs Market Size by Country
    • 11.3.1 Middle East & Africa Single-target MET TKIs Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Single-target MET TKIs Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Single-target MET TKIs Market Drivers
  • 12.2 Single-target MET TKIs Market Restraints
  • 12.3 Single-target MET TKIs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Single-target MET TKIs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Single-target MET TKIs
  • 13.3 Single-target MET TKIs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Single-target MET TKIs Typical Distributors
  • 14.3 Single-target MET TKIs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Single-target MET TKIs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Single-target MET tyrosine kinase inhibitors (TKIs) are drugs specifically designed to block the activity of the MET receptor tyrosine kinase alone, focusing on disrupting the MET signaling pathway that promotes cancer cell growth, survival, and metastasis.
    This report is a detailed and comprehensive analysis for global Single-target MET TKIs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Single-target MET TKIs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Single-target MET TKIs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Single-target MET TKIs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Single-target MET TKIs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Single-target MET TKIs
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Single-target MET TKIs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Merck, WuXi STA, Shanghai Hutchison Pharmaceuticals, Haihe Biopharma, CSPC Pharmaceutical, Avistone Pharmaceuticals Biotechnology, Asymchem, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Single-target MET TKIs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Capmatinib
    Tepotinib
    Savolitinib
    Glumetinib
    Vebreltinib
    Other
    Market segment by Application
    Hospital and Clinic
    Retail Pharmacies
    Other
    Major players covered
    Novartis
    Merck
    WuXi STA
    Shanghai Hutchison Pharmaceuticals
    Haihe Biopharma
    CSPC Pharmaceutical
    Avistone Pharmaceuticals Biotechnology
    Asymchem
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Single-target MET TKIs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Single-target MET TKIs, with price, sales quantity, revenue, and global market share of Single-target MET TKIs from 2021 to 2026.
    Chapter 3, the Single-target MET TKIs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Single-target MET TKIs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Single-target MET TKIs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Single-target MET TKIs.
    Chapter 14 and 15, to describe Single-target MET TKIs sales channel, distributors, customers, research findings and conclusion.

    Buy now